Thermo Fisher Scientific weighs in on the need for more disruptive technologies to advance healthcare in India during the Conference on Application of New-age technologies in Diagnostics

7th Oct 2022, New Delhi: Thermo Fisher Scientific, the world leader in serving science, recently participated in a conference on the Application of New-age Technologies in Diagnostics organized by the Confederation of Indian Industry (CII) Northern Regional Committee on Diagnostics and Technology.   CII is a non-government, not-for-profit, industry-led organization, that is engaged in creating…

Read More

Hospitals and pharmacies profit as 340B drives up patients’ drug costs

Original Source   The federal 340B Drug Pricing Program is starting to get a great deal of attention—for all the wrong reasons. The program was started in 1992 with the goal of allowing hospitals and clinics that work with underserved communities to provide outpatient prescription drugs to patients at deep discounts. Now, after 30 years,…

Read More

Biomanufacturing to get a boost from Biden’s new executive order

US President Joe Biden signed an executive order on Monday that will “help expand U.S. biomanufacturing and reduce reliance on China,” according to Bloomberg. The executive order will launch a National Biotechnology and Biomanufacturing Initiative that will accelerate biotechnology innovation and grow America’s bioeconomy across multiple sectors, including a range of industries, including health, agriculture, and energy, the White…

Read More

MMS Announces Key Executive Appointment to Support Company’s Next Stage of Growth

CANTON, Mich. (8/30/2022) – MMS Holdings Inc. (MMS) – a leading contract research organization (CRO) – announced the appointment of Kelly J. Hill to Chief Strategy Officer. This appointment reflects the company’s accelerating growth as it continues to deliver data-focused clinical research services. A long-time member of MMS’ executive leadership team, Hill brings more than 20…

Read More

CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods

The Cayman Biomedical Research Institute (CABRI) is pleased to announce a call for proposals that support essential research on specialized pro-resolving mediator (SPM) analytical methods. There is a critical need for basic research on analytical methods used for specialized pro-resolving mediators (SPMs). SPMs are a family of lipid metabolites derived from polyunsaturated fatty acids (PUFAs)…

Read More

House Passes CHIPS Act

President Biden signed into law the $280 billion CHIPS (Creating Helpful Incentives to Produce Semiconductors) and Science Act, a bill that would subsidize domestic semiconductor manufacturing and invest billions in science and technology innovation, in a bid to strengthen the United States’ competitiveness and self-reliance in what is seen as a keystone industry for economic and…

Read More

Senate Considers Drug Pricing Controls Legislation

In the waning days before the August recess, Senate Democrats are pushing legislation with anti-science drug price controls, as part of a so-called reconciliation bill. The legislation could undercut its own goals by depriving drugmakers of incentives for developing blockbuster medicines, plus lower-cost biosimilars and generics, several analysts and industry groups have warned. Predictions are that…

Read More

Efforts at value-based care focus on patients’ needs

Original Source What is the value of a treatment? As of July, the U.S. government has given out close to 600 million doses of COVID-19 vaccines at prices that ranged between $15-$20 per dose, which means they spent $10-$12 billion on shots. Research shows that, as of March, the U.S. vaccination program saved 2 million lives and $900 billion in…

Read More

Former Detroit radio voice takes cystic fibrosis fight to Egypt

Original Source   Laura Bonnell had a translator, because the parents in the room were mostly poor, and it’s typically the wealthy in Egypt who speak English. When the screen filled with a picture of her daughters, though — her strong, beautiful, living, 27- and 25-year-old babies — there was no need for words. The universal…

Read More

Price Controls Would Devastate Drug Development, Patient Access, Says New Analysis

Original Source: https://vitaltransformation.com/2022/07/build-back-better-act-total-market-impact-of-price-controls-in-medicare-parts-d-and-b/ Build Back Better Act Total market impact of price controls in Medicare parts D and B The Executive Summary The Build Back Better Act (BBBA) is designed to allow the US Government to ‘negotiate’ pricing under a set framework of reductions based upon the amount of time a drug has spent on…

Read More